The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression
Open accessAbstract
Nineteen benign [World Health Organization (WHO) grade I; MI], 21 atypical (WHO grade II; MII), and 19 anaplastic (WHO grade III; MIII) sporadic meningiomas were screened for chromosomal imbalances by comparative genomic hybridization (CGH). These data were supplemented by molecular genetic analyses of selected chromosomal regions and genes. With increasing malignancy grade, a marked accumulation of genomic aberrations was observed; i.e., the numbers (mean ± SEM) of total alterations detected per tumor were 2.9 ± 0.7 for MI, 9.2 ± 1.2 for MII, and 13.3 ± 1.9 for MIII. The most frequent alteration detected in MI was loss on 22q (58%). In MII, aberrations most commonly identified were losses on 1p (76%), 22q (71%), 14q (43%), 18q (43%), 10 (38%), and 6q (33%), as well as gains on 20q (48%), 12q (43%), 15q (43%), 1q (33%), 9q (33%), and 17q (33%). In MIII, most of these alterations were found at similar frequencies. However, an increase in losses on 6q (53%), 10 (68%), and 14q (63%) was observed. In addition, 32% of MIII demonstrated loss on 9p. Homozygous deletions in the CDKN2A gene at 9p21 were found in 4 of 16 MIII (25%). Highly amplified DNA sequences were mapped to 12q13–q15 by CGH in 1 MII. Southern blot analysis of this tumor revealed amplification of CDK4 and MDM2 . By CGH, DNA sequences from 17q were found to be amplified in 1 MII and 8 MIII, involving 17q23 in all cases. Despite the high frequency of chromosomal aberrations in the MII and MIII investigated, none of these tumors showed mutations in exons 5–8 of the TP53 gene. On the basis of the most common aberrations identified in the various malignancy grades, a model for the genomic alterations associated with meningioma progression is proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
Kallioniemi, A., Kallioniemi, O.-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., & Pinkel, D. (1992) · Science · doi:10.1126/science.1359641 · Cited by 3,297
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
The 1993–94 Généthon human genetic linkage map
Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M., & Weissenbach, J. (1994) · Nature Genetics · doi:10.1038/ng0694supp-246 · Cited by 1,835
— Tumors of the Central Nervous System
(2013) · Pediatric Radiotherapy Planning and Treatment · doi:10.1201/b14554-7 · Cited by 1,751
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, Preisinger, A. C., Thomas, G., Kinzler, K. W., et al. (1990) · Science · doi:10.1126/science.2294591 · Cited by 1,739
Histological Typing of Tumours of the Central Nervous System
Kleihues, P., Burger, P. C., & Scheithauer, B. W. (1993) · Springer eBooks · doi:10.1007/978-3-642-84988-6 · Cited by 1,532
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinänen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., & Kallioniemi, O.-P. (1995) · Nature Genetics · doi:10.1038/ng0495-401 · Cited by 1,484
Genetic progression model for head and neck cancer: implications for field cancerization.
Califano, J. A., van der Riet, P., Westra, W. H., Nawroz, H., Clayman, G. L., Piantadosi, S., Corio, R. L., Lee, D. J., Greenberg, B. M., Koch, W. M., et al. (1996) · PubMed · Cited by 1,355
Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
Hartwell, L. (1992) · Cell · doi:10.1016/0092-8674(92)90586-2 · Cited by 770
Kallioniemi, A., Kallioniemi, O. P., Piper, J., Tanner, M., Stokke, T., Chen, L., Smith, H. S., Pinkel, D., Gray, J. W., & Waldman, F. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2156 · Cited by 739
Mechanisms of Tumor Progression
Conti, C. J. (2010) · Comprehensive Toxicology · doi:10.1016/b978-0-08-046884-6.01417-2 · Cited by 608
Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas
Ruttledge, M. H., Sarrazin, J., Rangaratnam, S., Phelan, C. M., Twist, E. C., Merel, P., Delattre, O., Thomas, G. D., Nordenskjöld, M., Collins, V. P., et al. (1994) · Nature Genetics · doi:10.1038/ng0294-180 · Cited by 573
Self-citationdu Manoir, S., Speicher, M. R., Joos, S., Schröck, E., Popp, S., Döhner, H., Kovacs, G., Robert-Nicoud, M., Lichter, P., & Cremer, T. (1993) · Human Genetics · doi:10.1007/bf00202476 · Cited by 555
Self-citationCDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.
Schmidt, E., Ichimura, K., Reifenberger, G., & Collins, V. P. (1994) · PubMed · Cited by 508
Self-citationMechanisms of tumor progression.
Nowell, P. C. (1986) · PubMed · Cited by 440
CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., & Louis, D. N. (1996) · PubMed · Cited by 404
Mad-related genes in the human
Riggins, G. J., Thiagalingam, S., Rozenblum, E., Weinstein, C. L., Kern, S. E., Hamilton, S. R., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1996) · Nature Genetics · doi:10.1038/ng0796-347 · Cited by 306
Quantitative analysis of comparative genomic hybridization
du Manoir, S., Schröck, E., Bentz, M., Speicher, M. R., Joos, S., Ried, T., Lichter, P., & Cremer, T. (1995) · Cytometry · doi:10.1002/cyto.990190105 · Cited by 293
Self-citationClassic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance
Maier, H., Öfner, D., Hittmair, A., Kitz, K., & Budka, H. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.77.4.0616 · Cited by 283
Reifenberger, G., REIFENBERGER, J., Ichimura, K., Meltzer, P. S., & Collins, V. P. (1994) · PubMed · Cited by 279
Self-citationMitotic recombination of chromosome 17 in astrocytomas.
James, C. D., Carlbom, E., Nordenskjold, M., Collins, V. P., & Cavenee, W. K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2858 · Cited by 279
Self-citationIchimura, K., Schmidt, E., Goike, H., et al. (1996) · PubMed · Cited by 266
Ried, T., Just, K., Holtgreve-Grez, H., du Manoir, S., Speicher, M. R., Schröck, E., Latham, C., Blegen, H., Zetterberg, A., & Cremer, T. (1995) · PubMed · Cited by 229
Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system
Ohgaki, H., Eibl, R. H., Reichel, M. B., Mariani, L., Petersen, I., Höll, T., Wiestler, O. D., Kleihues, P., Schwab, M., & Gehring, M. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940080203 · Cited by 226
Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma.
Dumanski, J. P., Carlbom, E., Collins, V. P., & Nordenskjöld, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9275 · Cited by 214
Self-citationSimon, M., von Deimling, A., Larson, J. M., Wellenreuther, R., Kaskel, P., Waha, A., Warnick, R. E., Tew, J. M., & Menon, A. G. (1995) · PubMed · Cited by 211
Genomic instability in Ip and human malignancies
Schwab, M., Praml, C., & Amler, L. C. (1996) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199608)16:4<211::aid-gcc1>3.0.co;2-0 · Cited by 210
Cytological and cytogenetical studies on brain tumors
Zankl, H., & Zang, K. D. (1972) · Human Genetics · doi:10.1007/bf00273305 · Cited by 189
A tiger behind many doors: multiple genetic pathways to malignant glioma
Louis, D. N., & Gusella, J. F. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89125-8 · Cited by 185
Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.
Rasheed, B., McLendon, R. E., Friedman, H. S., Friedman, A. H., Fuchs, H. E., Bigner, D. D., & Bigner, S. H. (1995) · PubMed · Cited by 183
Reifenberger, J., Ring, G. U., Gies, U., Ludwig Cobbers, J. M. J., Oberstrab, J., An, H.-X., Niederacher, D., Wechsler, W., & Reifenberger, G. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199607000-00007 · Cited by 172
Self-citationRempel, S. A., Schwechheimer, K., Davis, R. L., Cavenee, W. K., & Rosenblum, M. L. (1993) · PubMed · Cited by 126
Identification by fluorescence of the G chromosome lost in human meningomas
Mark, J., Levan, G., & Mitelman, F. (2009) · Hereditas · doi:10.1111/j.1601-5223.1972.tb01017.x · Cited by 115
Infrequent alterations of thep15, p16, CDK4 andCYCLIN D1 genes in non-astrocytic human brain tumors
Sato, K., Schäuble, B., Kleihues, P., & Ohgaki, H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960503)66:3<305::aid-ijc6>3.0.co;2-2 · Cited by 80
Wang, J., Zhang, Z., Hartman, M., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640402 · Cited by 61
HUNTER, S. B., Abbott, K. L., VARMA, V. A., Olson, J. J., Barnett, D. W., & James, C. D. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199501000-00007 · Cited by 59
Analysis of glioma cell lines for amplification and overexpression of MDM2
He, J., Reifenberger, G., Liu, L., Collins, V. P., & James, C. D. (1994) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870110205 · Cited by 56
Self-citationP16 deletion and mutation analysis in human brain tumors
Barker, F. G., Chen, P., Furman, F., Aldape, K. D., Edwards, M. S. B., & Israel, M. A. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005768910871 · Cited by 44
Pykett, M. J., Landers, J. E., & George, D. L. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005779406636 · Cited by 15
Cited by
The WHO classification of tumors of the nervous system
Kleihues, P., Louis, D. N., Scheithauer, B. W., Rorke, L. B., Reifenberger, G., Burger, P. C., & Cavenee, W. K. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.215 · Cited by 1,547
Self-citationHistological classification and molecular genetics of meningiomas
Riemenschneider, M. J., Perry, A., & Reifenberger, G. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70625-1 · Cited by 573
Self-citation“Malignancy” in meningiomas: A clinicopathologic study of 116 patients, with grading implications
Perry, A., Scheithauer, B. W., Stafford, S. L., Lohse, C. M., & Wollan, P. C. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990501)85:9%3c2046::aid-cncr23%3e3.0.co;2-m · Cited by 530
A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells
Zhang, X., Zhou, Y., Mehta, K. R., Danila, D. C., Scolavino, S., Johnson, S. R., & Klibanski, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030222 · Cited by 435
Jacobs, J. J. L., Keblusek, P., Robanus-Maandag, E., Kristel, P., Lingbeek, M., Nederlof, P. M., van Welsem, T., van de Vijver, M. J., Koh, E. Y., Daley, G. Q., et al. (2000) · Nature Genetics · doi:10.1038/81583 · Cited by 368
Metadata
- Authors
- Weber, R. G., Boström, J., Wolter, M., Baudis, M., Collins, V. P., Reifenberger, G., & Lichter, P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-12-23
- Volume
- 94
- Issue
- 26
- Pages
- 14719-14724
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2041025015
- Cited by
- 407
- References
- 46
- FWCI
- 11.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.